These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 14392686)

  • 1. [Studies on the growth of mycobacterium tuberculosis. IX. The effects of sodium lauryl sulfate upon the variation of Mycobacterium tuberculosis and saprophytic acid-fast bacilli. 3. The changes in immunity and toxicity of BCG and Mycobacterium tuberculosis var. hominis F. induced by the repeated subculture on Oka-Katakura's media containing sodium lauryl sulfate].
    YOSHIDA N; ISHIMARU S
    Kekkaku; 1955 Apr; 30(4):180-2; English summary, 210-1. PubMed ID: 14392686
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the growth of mycobacterium tuberculosis. X. The effect of sodium lauryl sulfate upon the variation of mycobacterium tuberculosis and saprophytic acid-fast bacilli. 4. Difference in the degree of immunity acquired by the subcutaneous inoculation of 1.5 mg and 1.0 mg of BCG].
    YOSHIDA N; ISHIMARU S
    Kekkaku; 1955 May; 30(5):217-9; English summary, 255. PubMed ID: 14392692
    [No Abstract]   [Full Text] [Related]  

  • 3. Niacin test for differentiation of Mycobacterium tuberculosis var. hominis from other acid-fast bacilli. XI. Clinical and bacteriological examination of the 2 cases with pulmonary tuberculosis which had excreted niacin test negative mycobacterium tuberculosis var. hominis for a long period. II. Some properties of the acid-fast bacilli detected.
    Ogawa T; Hatanaka E; Nishimura S; Saito K
    Kitasato Arch Exp Med; 1968 Dec; 41(3):89-98. PubMed ID: 4981548
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on the culture of mycobacterium tuberculosis. I. Comparison between one time and three times heated Oka-Katakura's media].
    ITO Y
    Kekkaku; 1955 Apr; 30(4):190-3; English summary, 212. PubMed ID: 14392688
    [No Abstract]   [Full Text] [Related]  

  • 5. [Niacin test for differentiation of mycobacterium tuberculosis var. hominis from other acid-fast bacilli. IX. Niacin test on human tubercle bacilli rendered resistant to multiple drugs in vitro].
    Ogawa T
    Kekkaku; 1967 May; 42(5):187-91. PubMed ID: 4964921
    [No Abstract]   [Full Text] [Related]  

  • 6. Niacin test for differentiation of Mycobacterium tuberculosis var. hominis from other acid-fast bacilli. XII. Clinical and bacteriological examination of 2 cases with pulmonary tuberculosis which had excreted niacin test negative Mycobacterium tuberculosis var. hominis for a long period. 3. Animal inoculation of the detected acid-fast bacilli.
    Ogawa T; Hatanaka E; Nishimura S
    Kitasato Arch Exp Med; 1968 Dec; 41(3):99-112. PubMed ID: 4981549
    [No Abstract]   [Full Text] [Related]  

  • 7. Niacin test for differentiation of Mycobacterium tuberculosis var. hominis from other acid-fast bacilli. X. Clinical and bacteriological examination of the 2 cases with pulmonary tuberculosis which had excreted niacin test negative mycobacterium tuberculosis var. hominis for a long period. I. Clinical observation.
    Ogawa T; Hatanaka E; Nishimura S; Saito K
    Kitasato Arch Exp Med; 1968 Dec; 41(3):77-87. PubMed ID: 4981547
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the mechanism of development of SM resistancy in Mycobacterium tuberculosis var. hominis. II. Effects of SM on the morphological changes of human type tubercle bacilli].
    HATANO S
    Kekkaku; 1956 Dec; 31(12):723-7. PubMed ID: 13406902
    [No Abstract]   [Full Text] [Related]  

  • 9. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
    Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
    J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antigenic similarities between Mycobacterium tuberculosis and other acid-fast saprophytic strains of Mycobacterium].
    MRSEVIC S; DORDEVIC L
    Hig Cas Hig Mikrobiol Epidemiol Sanit Teh; 1958; 10(2):132-6. PubMed ID: 13598363
    [No Abstract]   [Full Text] [Related]  

  • 11. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice.
    Giri PK; Verma I; Khuller GK
    J Infect; 2006 Nov; 53(5):350-6. PubMed ID: 16442629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice.
    Luo Y; Wang B; Hu L; Yu H; Da Z; Jiang W; Song N; Qie Y; Wang H; Tang Z; Xian Q; Zhang Y; Zhu B
    Vaccine; 2009 Oct; 27(44):6179-85. PubMed ID: 19712772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and immunogenicity of recombinant Mycobacterium bovis Bacillus Calmette-Guérin strains secreting the antigen ESAT-6 from Mycobacterium tuberculosis in mice.
    Wang LM; Shi CH; Fan XL; Xue Y; Bai YL; Xu ZK
    Chin Med J (Engl); 2007 Jul; 120(14):1220-5. PubMed ID: 17697571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
    Mollenkopf HJ; Kursar M; Kaufmann SH
    J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the antigenic repertoire of BCG improves protective efficacy against aerosol Mycobacterium tuberculosis infection.
    Palendira U; Spratt JM; Britton WJ; Triccas JA
    Vaccine; 2005 Feb; 23(14):1680-5. PubMed ID: 15705472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine-induced cytokine responses in a guinea pig model of pulmonary tuberculosis.
    McMurray DN; Allen SS; Jeevan A; Lasco T; Cho H; Skwor T; Yamamoto T; McFarland C; Yoshimura T
    Tuberculosis (Edinb); 2005; 85(5-6):295-301. PubMed ID: 16253558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A study of the protective effect of the DNA vaccine encoding tubercle antigen 85B with MPT64 in mice challenged with Mycobacterium tuberculosis].
    Luo XD; Zhu DY; Chen Q; Jiang Y; Jiang S; Yang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Sep; 27(9):611-6. PubMed ID: 15498274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages.
    Khan A; Sarkar S; Sarkar D
    Int J Antimicrob Agents; 2008 Jul; 32(1):40-5. PubMed ID: 18538548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.